CIK 0001176309
- Non-accelerated filer
- Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980376008
- Phone
- +1 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-11 | KIDRON NADAV President and CEO | Grant or award | +100,000 | 2,686,598 | ||
| 2025-01-02 | KIDRON NADAV President and CEO | Grant or award | +433,500 | 2,259,598 | ||
| 2024-11-07 | KIDRON NADAV President and CEO | Grant or award | +45,000 | 1,826,098 | ||
| 2024-01-04 | KIDRON NADAV President and CEO | Grant or award | +329,000 | 1,781,098 | ||
| 2023-05-26 | KIDRON NADAV President and CEO | Grant or award | +120,000 | 1,452,098 | ||
| 2023-04-17 | KIDRON NADAV President and CEO | Grant or award | +279,000 | 1,332,098 | ||
| 2023-03-16 | KIDRON NADAV President and CEO | Purchase | +26,000 | $2.04 | $53K | 126,000 |
| 2023-03-14 | KIDRON NADAV President and CEO | Purchase | +100,000 | $2.01 | $201K | 100,000 |
| 2022-10-27 | KIDRON NADAV President and CEO | Gift | −25,000 | 1,053,098 | ||
| 2022-08-01 | KIDRON NADAV President and CEO | Shares withheld for taxes | −12,631 | $8.36 | $106K | 1,078,098 |
| 2022-07-28 | KIDRON NADAV President and CEO | Grant or award | +34,000 | 964,729 | ||
| 2022-07-28 | KIDRON NADAV President and CEO | Grant or award | +126,000 | 1,090,729 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award | +150,000 | 916,481 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Shares withheld for taxes | −48,752 | $13.89 | $677K | 867,729 |
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award | +63,000 | 930,729 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy | +107,000 | 107,000 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award | +150,000 | 936,481 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Shares withheld for taxes | −48,752 | $13.89 | $677K | 887,729 |
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award | +63,000 | 950,729 | ||
| 2022-01-03 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy | +107,000 | 107,000 |
Page 2 of 4 · 76 trades